CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 18 filers reported holding CHEMBIO DIAGNOSTICS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $707,000 | +6.6% | 138,080 | -5.1% | 0.14% | +74.4% |
| Q4 2019 | $663,000 | -21.8% | 145,431 | +4.9% | 0.08% | -32.8% |
| Q3 2019 | $848,000 | -9.8% | 138,603 | -10.2% | 0.12% | -5.4% |
| Q2 2019 | $940,000 | +1780.0% | 154,407 | +1139.1% | 0.13% | +1512.5% |
| Q3 2015 | $50,000 | -18.0% | 12,461 | 0.0% | 0.01% | -11.1% |
| Q2 2015 | $61,000 | +22.0% | 12,461 | 0.0% | 0.01% | +28.6% |
| Q1 2015 | $50,000 | -10.7% | 12,461 | -13.4% | 0.01% | -12.5% |
| Q4 2014 | $56,000 | -6.7% | 14,388 | -10.8% | 0.01% | -11.1% |
| Q3 2014 | $60,000 | +46.3% | 16,133 | +41.7% | 0.01% | +50.0% |
| Q3 2013 | $41,000 | -77.3% | 11,387 | -68.6% | 0.01% | -81.2% |
| Q2 2013 | $181,000 | – | 36,213 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
| Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
| P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
| PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
| Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
| SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
| Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
| SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |